Orzel Spolka Akcyjna Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Orzel Spolka Akcyjna zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Chemicals earnings growth | 21.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Calculating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)
Dec 22
If EPS Growth Is Important To You, Orzel Spolka Akcyjna (WSE:ORL) Presents An Opportunity
Sep 29Should You Be Adding Orzel Spolka Akcyjna (WSE:ORL) To Your Watchlist Today?
May 13If You Like EPS Growth Then Check Out Orzel Spolka Akcyjna (WSE:ORL) Before It's Too Late
Jan 25Estimating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)
Aug 03A Look At The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)
Mar 12Orzel Spolka Akcyjna (WSE:ORL) Has A Somewhat Strained Balance Sheet
Dec 11
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Orzel Spolka Akcyjna has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 17 | 2 | -9 | 4 | N/A |
| 9/30/2023 | 18 | 3 | -4 | 5 | N/A |
| 6/30/2023 | 16 | 2 | 0 | 3 | N/A |
| 3/31/2023 | 15 | 2 | 3 | 3 | N/A |
| 12/31/2022 | 15 | 3 | 3 | 3 | N/A |
| 9/30/2022 | 14 | 2 | 2 | 3 | N/A |
| 6/30/2022 | 14 | 2 | 3 | 4 | N/A |
| 3/31/2022 | 14 | 3 | 2 | 4 | N/A |
| 12/31/2021 | 13 | 3 | 2 | 4 | N/A |
| 9/30/2021 | 12 | 2 | 1 | 3 | N/A |
| 6/30/2021 | 12 | 2 | 1 | 2 | N/A |
| 3/31/2021 | 12 | 1 | 2 | 3 | N/A |
| 12/31/2020 | 11 | 1 | 2 | 2 | N/A |
| 9/30/2020 | 11 | 1 | 2 | 3 | N/A |
| 6/30/2020 | 11 | 2 | 2 | 3 | N/A |
| 3/31/2020 | 11 | 2 | 3 | 3 | N/A |
| 12/31/2019 | 12 | 2 | 2 | 3 | N/A |
| 9/30/2019 | 11 | 2 | 2 | 2 | N/A |
| 6/30/2019 | 11 | 1 | 2 | 2 | N/A |
| 3/31/2019 | 10 | 1 | 1 | 1 | N/A |
| 12/31/2018 | 10 | 1 | 2 | 2 | N/A |
| 9/30/2018 | 11 | 0 | 1 | 2 | N/A |
| 6/30/2018 | 10 | 0 | 1 | 1 | N/A |
| 3/31/2018 | 9 | -1 | 0 | 1 | N/A |
| 12/31/2017 | 9 | -1 | 0 | 0 | N/A |
| 9/30/2017 | 8 | -2 | N/A | 0 | N/A |
| 6/30/2017 | 8 | -2 | N/A | 0 | N/A |
| 3/31/2017 | 7 | -2 | N/A | 0 | N/A |
| 12/31/2016 | 6 | -1 | N/A | 0 | N/A |
| 9/30/2016 | 6 | -2 | N/A | 0 | N/A |
| 6/30/2016 | 6 | -1 | N/A | 1 | N/A |
| 3/31/2016 | 6 | -2 | N/A | 1 | N/A |
| 12/31/2015 | 6 | -2 | N/A | 1 | N/A |
| 9/30/2015 | 6 | -3 | N/A | 3 | N/A |
| 6/30/2015 | 6 | -3 | N/A | 2 | N/A |
| 3/31/2015 | 6 | -4 | N/A | 3 | N/A |
| 12/31/2014 | 7 | -5 | N/A | 2 | N/A |
| 9/30/2014 | 17 | -3 | N/A | 0 | N/A |
| 6/30/2014 | 23 | -4 | N/A | 1 | N/A |
| 3/31/2014 | 31 | -3 | N/A | 3 | N/A |
| 12/31/2013 | 34 | -4 | N/A | 1 | N/A |
| 9/30/2013 | 37 | -5 | N/A | 2 | N/A |
| 6/30/2013 | 34 | -4 | N/A | 2 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von ORL über der Sparquote liegt (3.6%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von ORL schneller wachsen werden als der Markt Polish
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von ORL in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von ORL schneller wachsen werden als der Markt von Polish.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von ORL schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von ORL in 3 Jahren voraussichtlich hoch sein wird